IP GROUP PLC LS -02

Research IP GROUP PLC LS -02 (IOOA) on Bullrun: market cap EUR 737.66M, P/E 10.4. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 737.66M; P/E is 10.4.

Peer valuation comparison

Latest P/E is 10.44x versus a Financial Services sector median of 13.84x (24.6% below).

Latest P/E is 10.44x versus a United Kingdom median of 16.18x (35.5% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 90.60MGBP 66.90M-GBP 19.60Mn/a0.07GBP 16.50MGBP 119.70MGBP 975.10M
FY2024-GBP 179.50M-GBP 207.00M-GBP 25.10Mn/a-0.2GBP 115.60MGBP 150.00MGBP 966.00M
FY2023-GBP 145.70M-GBP 171.30M-GBP 17.90Mn/a-0.17GBP 100.90MGBP 156.40MGBP 1.20B
FY2022-GBP 313.20M-GBP 341.50M-GBP 23.80Mn/a-0.33GBP 88.70MGBP 101.80MGBP 1.38B
FY2021n/aGBP 449.30MGBP 9.80Mn/a0.42GBP 105.70MGBP 51.80MGBP 1.74B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25EUR 737.66M10.4n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

YearDividends/share
FY20230.01 GBP
FY20220.01 GBP
FY20210.02 GBP

About IP GROUP PLC LS -02

IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is IP GROUP PLC LS -02's market cap?

IP GROUP PLC LS -02's market capitalization is EUR 737.66M.

What is IP GROUP PLC LS -02's P/E ratio?

IP GROUP PLC LS -02's price-to-earnings (P/E) ratio is 10.4.

What does IP GROUP PLC LS -02 do?

IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe, typically invests in companies based in or willing to relocate to North East England.